215 related articles for article (PubMed ID: 38187660)
1. Spatial analysis of NOS2 and COX2 interaction with T-effector cells reveals immunosuppressive landscapes associated with poor outcome in ER- breast cancer patients.
Ridnour LA; Cheng RYS; Heinz WF; Pore M; Gonzalez AL; Femino EL; Moffat R; Wink AL; Imtiaz F; Coutinho L; Butcher D; Edmondson EF; Rangel MC; Wong STC; Lipkowitz S; Glynn S; Vitek MP; McVicar DW; Li X; Anderson SK; Paolocci N; Hewitt SM; Ambs S; Billiar TR; Chang JC; Lockett SJ; Wink DA
bioRxiv; 2023 Dec; ():. PubMed ID: 38187660
[TBL] [Abstract][Full Text] [Related]
2. NOS2 and COX2 Provide Key Spatial Targets that Determine Outcome in ER- Breast Cancer.
Ridnour LA; Heinz WF; Cheng RY; Wink AL; Kedei N; Pore M; Imtiaz F; Femino EL; Gonzalez AL; Coutinho L; Butcher D; Edmondson EF; Rangel MC; Kinders RJ; Lipkowitz S; Wong ST; Anderson SK; McVicar DW; Li X; Glynn SA; Billiar TR; Chang JC; Hewitt SM; Ambs S; Lockett SJ; Wink DA
bioRxiv; 2023 Dec; ():. PubMed ID: 38187532
[TBL] [Abstract][Full Text] [Related]
3. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density.
Somasundaram V; Ridnour LA; Cheng RY; Walke AJ; Kedei N; Bhattacharyya DD; Wink AL; Edmondson EF; Butcher D; Warner AC; Dorsey TH; Scheiblin DA; Heinz W; Bryant RJ; Kinders RJ; Lipkowitz S; Wong ST; Pore M; Hewitt SM; McVicar DW; Anderson SK; Chang J; Glynn SA; Ambs S; Lockett SJ; Wink DA
Redox Biol; 2022 Dec; 58():102529. PubMed ID: 36375380
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma is Quintessential for NOS2 and COX2 Expression in ER
Cheng RY; Ridnour LA; Wink AL; Gonzalez AL; Femino EL; Rittscher H; Somasundarum V; Heinz WF; Coutinho L; Cristina Rangel M; Edmondson EF; Butcher D; Kinders RJ; Li X; Wong STC; McVicar DW; Anderson SK; Pore M; Hewitt SM; Billiar TR; Glynn S; Chang JC; Lockett SJ; Ambs S; Wink DA
bioRxiv; 2023 Apr; ():. PubMed ID: 37066331
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma is quintessential for NOS2 and COX2 expression in ER
Cheng RYS; Ridnour LA; Wink AL; Gonzalez AL; Femino EL; Rittscher H; Somasundaram V; Heinz WF; Coutinho L; Rangel MC; Edmondson EF; Butcher D; Kinders RJ; Li X; Wong STC; McVicar DW; Anderson SK; Pore M; Hewitt SM; Billiar TR; Glynn SA; Chang JC; Lockett SJ; Ambs S; Wink DA
Cell Death Dis; 2023 May; 14(5):319. PubMed ID: 37169743
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
Basudhar D; Glynn SA; Greer M; Somasundaram V; No JH; Scheiblin DA; Garrido P; Heinz WF; Ryan AE; Weiss JM; Cheng RYS; Ridnour LA; Lockett SJ; McVicar DW; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):13030-13035. PubMed ID: 29087320
[TBL] [Abstract][Full Text] [Related]
7. KLF5 inhibition potentiates anti-PD1 efficacy by enhancing CD8
Wu Q; Liu Z; Gao Z; Luo Y; Li F; Yang C; Wang T; Meng X; Chen H; Li J; Kong Y; Dong C; Sun S; Chen C
Theranostics; 2023; 13(4):1381-1400. PubMed ID: 36923542
[No Abstract] [Full Text] [Related]
8. [Immunosuppressive Environment in Tumors].
Sakai C; Nishikawa H
Gan To Kagaku Ryoho; 2018 Feb; 45(2):222-226. PubMed ID: 29483409
[TBL] [Abstract][Full Text] [Related]
9. Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level.
Somasundaram V; Gilmore AC; Basudhar D; Palmieri EM; Scheiblin DA; Heinz WF; Cheng RYS; Ridnour LA; Altan-Bonnet G; Lockett SJ; McVicar DW; Wink DA
Redox Biol; 2020 Jan; 28():101354. PubMed ID: 31683257
[TBL] [Abstract][Full Text] [Related]
10. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).
Whiteside TL; Mandapathil M; Schuler P
Curr Med Chem; 2011; 18(34):5217-23. PubMed ID: 22087822
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.
Huang P; Zhou X; Zheng M; Yu Y; Jin G; Zhang S
Front Immunol; 2023; 14():1263537. PubMed ID: 37767092
[TBL] [Abstract][Full Text] [Related]
12. Regulation of COX2 expression in mouse mammary tumor cells controls bone metastasis and PGE2-induction of regulatory T cell migration.
Karavitis J; Hix LM; Shi YH; Schultz RF; Khazaie K; Zhang M
PLoS One; 2012; 7(9):e46342. PubMed ID: 23029485
[TBL] [Abstract][Full Text] [Related]
13. Immune parameters associated with survival in metaplastic breast cancer.
Chao X; Liu L; Sun P; Yang X; Li M; Luo R; Huang Y; He J; Yun J
Breast Cancer Res; 2020 Aug; 22(1):92. PubMed ID: 32811533
[TBL] [Abstract][Full Text] [Related]
14. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
15. IDO1/COX2 Expression Is Associated with Poor Prognosis in Colorectal Cancer Liver Oligometastases.
Wu M; Wu X; Wang X; Hong X; Liu Y; Lv G; Li C; Pan Z; Zhang R; Chen G
J Pers Med; 2023 Mar; 13(3):. PubMed ID: 36983678
[TBL] [Abstract][Full Text] [Related]
16. Indoleamine-2,3-dioxygenase 1/cyclooxygenase 2 expression prediction for adverse prognosis in colorectal cancer.
Ma WJ; Wang X; Yan WT; Zhou ZG; Pan ZZ; Chen G; Zhang RX
World J Gastroenterol; 2018 May; 24(20):2181-2190. PubMed ID: 29853736
[TBL] [Abstract][Full Text] [Related]
17. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression.
Heinecke JL; Ridnour LA; Cheng RY; Switzer CH; Lizardo MM; Khanna C; Glynn SA; Hussain SP; Young HA; Ambs S; Wink DA
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6323-8. PubMed ID: 24733928
[TBL] [Abstract][Full Text] [Related]
18. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry.
Soliman H; Rawal B; Fulp J; Lee JH; Lopez A; Bui MM; Khalil F; Antonia S; Yfantis HG; Lee DH; Dorsey TH; Ambs S
Cancer Immunol Immunother; 2013 May; 62(5):829-37. PubMed ID: 23344392
[TBL] [Abstract][Full Text] [Related]
19. NOS2 as an Emergent Player in Progression of Cancer.
Thomas DD; Wink DA
Antioxid Redox Signal; 2017 Jun; 26(17):963-965. PubMed ID: 28506076
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
